Pathophysiological role of inflammatory molecules in paediatric ischaemic brain injury

European Journal of Clinical Investigation

Volumn 42, Issue 7, 2012, Pages 784-794

  Mirabelli Badenier, Marisol ^a   Braunersreuther, Vincent ^b   Lenglet, Sébastien ^b   Galan, Katia ^b   Veneselli, Edvige ^a   Viviani, Giorgio L ^c   Mach, François ^b   Montecucco, Fabrizio ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Chemokines; Cytokines; Inflammatory mediators; Paediatric stroke

Indexed keywords

2 IMINOBIOTIN; 7 NITROINDAZOLE; ACETYLCYSTEINE; ALLOPURINOL; AMINOGUANIDINE; ANTIINFLAMMATORY AGENT; BIOTIN DERIVATIVE; C REACTIVE PROTEIN; DEFEROXAMINE; GALECTIN 3; GAMMA INTERFERON; HYDROGEN PEROXIDE; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MELATONIN; MINOCYCLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; OXIDIZING AGENT; RANTES; SIMVASTATIN; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

BRAIN DISEASE; BRAIN ISCHEMIA; DRUG TARGETING; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INDUCED HYPOTHERMIA; INFLAMMATION; MOLECULAR MECHANICS; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PERINATAL ASPHYXIA; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

BRAIN INJURIES; BRAIN ISCHEMIA; CHEMOKINES; CHILD; CHILD, PRESCHOOL; CYTOKINES; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION MEDIATORS; MODELS, ANIMAL; OXIDANTS;

EID: 84862622141     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2012.02640.x     Document Type: Review

References (94)

1. Christerson S, Strömberg B. Childhood stroke in Sweden I: incidence, symptoms, risk factors and short-term outcome. Acta Paediatr 2010;99:1650-6.
2. Nestoridi E, Buonanno FS, Jones RM, Krishnamoorthy K, Grant PE, Van Cott EM et al. Arterial ischemic stroke in childhood: the role of plasma-phase risk factors. Curr Opin Neurol 2002;15:139-44.
3. Lynch JK, Hirtz DG, DeVeber G, Nelson KB. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics 2002;109:116-23.
4. Lopez-Vicente M, Ortega-Gutierrez S, Amlie-Lefond C, Torbey MT. Diagnosis and management of pediatric arterial ischemic stroke. J Stroke Cerebrovasc Dis 2010;19:175-83.
5. Raju TN, Nelson KB, Ferriero D, Lynch JK; NICHD-NINDS Perinatal Stroke Workshop Participants. Ischemic perinatal stroke: summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke. Pediatrics 2007;120:609-16.
6. Chabrier S, Husson B, Dinomais M, Landrieu P, Nguyen The Tich S. New insights (and new interrogations) in perinatal arterial ischemic stroke. Thromb Res 2011;127:13-22.
7. Fullerton HJ, Wu YW, Zhao S, Johnston SC. Risk of stroke in children: ethnic and gender disparities. Neurology 2003;61:189-94.
8. Agrawal N, Johnston SC, Wu YW, Sidney S, Fullerton HJ. Imaging data reveal a higher pediatric stroke incidence than prior US estimates. Stroke 2009;40:3415-21.
9. Benders MJ, Groenendaal F, De Vries LS. Preterm arterial ischemic stroke. Semin Fetal Neonatal Med 2009;14:272-7.
10. Amlie-Lefond C, Sébire G, Fullerton HJ. Recent developments in childhood arterial ischaemic stroke. Lancet Neurol 2008;7:425-35.
11. Härtel C, Schilling S, Sperner J, Thyen U. The clinical outcomes of neonatal and childhood stroke: review of the literature and implications for future research. Eur J Neurol 2004;11:431-8.
12. Cárdenas JF, Rho JM, Kirton A. Pediatric stroke. Childs Nerv Syst 2011;27:1375-90.
13. deVeber GA, MacGregor D, Curtis R, Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol 2000;15:316-24.
14. Cappa SF, Papagno C, Vallar G. Language and verbal memory after right hemispheric stroke: a clinical-CT scan study. Neuropsychologia 1990;28:503-9.
15. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001;50:553-62.
16. Distefano G, Praticò AD. Actualities on molecular pathogenesis and repairing processes of cerebral damage in perinatal hypoxic-ischemic encephalopathy. Ital J Pediatr 2010;36:63.
17. Powell FC, Hanigan WC, McCluney KW. Subcortical infarction in children. Stroke 1994;25:117-21.
18. Brower MC, Rollins N, Roach ES. Basal ganglia and thalamic infarction in children. Cause and clinical features. Arch Neurol 1996;53:1252-6.
19. Ganesan V, Hogan A, Shack N, Gordon A, Isaacs E, Kirkham FJ. Outcome after ischaemic stroke in childhood. Dev Med Child Neurol 2000;42:455-61.
20. Trauner DA, Nass R, Ballantyne A. Behavioural profiles of children and adolescents after pre- or perinatal unilateral brain damage. Brain 2001;124:995-1002.
21. Gordon A, Barnes C, Mackay M. Paediatric stroke: the need for interdisciplinary models of care. J Paediatr Child Health 2009;45:243-5.
22. Mirabelli-Badenier M, Braunersreuther V, Viviani GL, Dallegri F, Quercioli A, Veneselli E et al. CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. Thromb Haemost 2011;105:409-20.
23. Kadhim HJ, Duchateau J, Sébire G. Cytokines and brain injury: invited review. J Intensive Care Med 2008;23:236-49.
24. Ferriero DM. Neonatal brain injury. N Engl J Med 2004;351:1985-95.
25. McQuillen PS, Ferriero DM. Selective vulnerability in the developing central nervous system. Pediatr Neurol 2004;30:227-35.
26. Leviton A, Dammann O. Coagulation, inflammation, and the risk of neonatal white matter damage. Pediatr Res 2004;55:541-5.
27. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998;44:665-75.
28. Vexler ZS, Yenari MA. Does inflammation after stroke affect the developing brain differently than adult brain? Dev Neurosci 2009;31:378-93.
29. Hagberg H, Gilland E, Bona E, Hanson LA, Hahin-Zoric M, Blennow M et al. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 1996;40:603-9.
30. Anthony DC, Bolton SJ, Fearn S, Perry VH. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 1997;120:435-44.
31. Girard S, Kadhim H, Larouche A, Roy M, Gobeil F, Sébire G. Pro-inflammatory disequilibrium of the IL-1 beta/IL-1ra ratio in an experimental model of perinatal brain damages induced by lipopolysaccharide and hypoxia-ischemia. Cytokine 2008;43:54-62.
32. Hedtjärn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002;22:5910-9.
33. Hedtjärn M, Mallard C, Iwakura Y, Hagberg H. Combined deficiency of IL-1beta18, but not IL-1alphabeta, reduces susceptibility to hypoxia-ischemia in the immature brain. Dev Neurosci 2005;27: 143-8.
34. Wheeler RD, Boutin H, Touzani O, Luheshi GN, Takeda K, Rothwell NJ. No role for interleukin-18 in acute murine stroke-induced brain injury. J Cereb Blood Flow Metab 2003;23:531-5.
35. Szaflarski J, Burtrum D, Silverstein FS. Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke 1995;26:1093-100.
36. Mann SA, Versmold B, Marx R, Stahlhofen S, Dietzel ID, Heumann R et al. Corticosteroids reverse cytokine-induced block of survival and differentiation of oligodendrocyte progenitor cells from rats. J Neuroinflammation 2008;5:39.
37. Fontaine RH, Cases O, Lelièvre V, Mesplès B, Renauld JC, Loron G et al. IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. Cell Death Differ 2008;15:1542-52.
38. Patkai J, Mesples B, Dommergues MA, Fromont G, Thornton EM, Renauld JC et al. Deleterious effects of IL-9-activated mast cells and neuroprotection by antihistamine drugs in the developing mouse brain. Pediatr Res 2001;50:222-30.
39. Sharma S, Yang B, Xi X, Grotta JC, Aronowski J, Savitz SI. IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain Res 2011;1373:189-94.
40. Mesples B, Plaisant F, Gressens P. Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice. Brain Res Dev Brain Res 2003;141:25-32.
41. Dommergues MA, Patkai J, Renauld JC, Evrard P, Gressens P. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 2000;47:54-63.
42. Garg SK, Kipnis J, Banerjee R. IFN-gamma and IL-4 differentially shape metabolic responses and neuroprotective phenotype of astrocytes. J Neurochem 2009;108:1155-66.
43. Bona E, Andersson AL, Blomgren K, Gilland E, Puka-Sundvall M, Gustafson K et al. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr Res 1999;45:500-9.
44. Montecucco F, Burger F, Mach F, Steffens S. CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. Am J Physiol Heart Circ Physiol 2008;294:H1145-55.
45. Hughes PM, Allegrini PR, Rudin M, Perry VH, Mir AK, Wiessner C. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Meta 2002;22:308-17.
46. Schilling M, Strecker JK, Schäbitz WR, Ringelstein EB, Kiefer R. Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience 2009;161:806-12.
47. Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 2007;38:1345-53.
48. Minami M, Satoh M. Chemokines and their receptors in the brain: pathophysiological roles in ischemic brain injury. Life Sci 2003;74:321-7.
49. Galasso JM, Miller MJ, Cowell RM, Harrison JK, Warren JS, Silverstein FS. Acute excitotoxic injury induces expression of monocyte chemoattractant protein-1 and its receptor, CCR2, in neonatal rat brain. Exp Neurol 2000;165:295-305.
50. Galasso JM, Liu Y, Szaflarski J, Warren JS, Silverstein FS. Monocyte chemoattractant protein-1 is a mediator of acute excitotoxic injury in neonatal rat brain. Neuroscience 2000;101:737-44.
51. Denker SP, Ji S, Dingman A, Lee SY, Derugin N, Wendland MF et al. Macrophages are comprised of resident brain microglia not infiltrating peripheral monocytes acutely after neonatal stroke. J Neurochem 2007;100:893-904.
52. Miller JT, Bartley JH, Wimborne HJ, Walker AL, Hess DC, Hill WD et al. The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. BMC Neurosci 2005;6:63.
53. Khan JY, Black SM. Developmental changes in murine brain antioxidant enzymes. Pediatr Res 2003;54:77-82.
54. Spanggord H, Sheldon RA, Ferriero DM. Cysteamine eliminates nitric oxide synthase activity but is not protective to the hypoxic-ischemic neonatal rat brain. Neurosci Lett 1996;213:41-4.
55. Ditelberg JS, Sheldon RA, Epstein CJ, Ferriero DM. Brain injury after perinatal hypoxia-ischemia is exacerbated in copper/zinc superoxide dismutase transgenic mice. Pediatr Res 1996;39:204-8.
56. Lafemina MJ, Sheldon RA, Ferriero DM. Acute hypoxia-ischemia results in hydrogen peroxide accumulation in neonatal but not adult mouse brain. Pediatr Res 2006;59:680-3.
57. Sheldon RA, Jiang X, Francisco C, Christen S, Vexler ZS, Tauber MG et al. Manipulation of antioxidant pathways in neonatal murine brain. Pediatr Res 2004;56:656-62.
58. Sheldon RA, Christen S, Ferriero DM. Genetic and pharmacologic manipulation of oxidative stress after neonatal hypoxia-ischemia. Int J Dev Neurosci 2008;26:87-92.
59. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 1997;17:9157-64.
60. Peeters-Scholte C, Koster J, Veldhuis W, van den Tweel E, Zhu C, Kops N et al. Neuroprotection by selective nitric oxide synthase inhibition at 24h after perinatal hypoxia-ischemia. Stroke 2002;33:2304-10.
61. Higuchi Y, Hattori H, Kume T, Tsuji M, Akaike A, Furusho K. Increase in nitric oxide in the hypoxic-ischemic neonatal rat brain and suppression by 7-nitroindazole and aminoguanidine. Eur J Pharmacol 1998;342:47-9.
62. Tsuji M, Higuchi Y, Shiraishi K, Kume T, Akaike A, Hattori H. Protective effect of aminoguanidine on hypoxic-ischemic brain damage and temporal profile of brain nitric oxide in neonatal rat. Pediatr Res 2000;47:79-83.
63. Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997;17:2746-55.
64. Vexler ZS, Tang XN, Yenari MA. Inflammation in adult and neonatal stroke. Clin Neurosci Res 2006;6:293-13.
65. Yang L, Sameshima H, Yamaguchi M, Ikenoue T. Expression of inducible nitric oxide synthase and cyclooxygenase-2 mRNA in brain damage induced by lipopolysaccharide and intermittent hypoxia-ischemia in neonatal rats. J Obstet Gynaecol Res 2005;31: 185-91.
66. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001;286:954-9.
67. Candelario-Jalil E. Nimesulide as a promising neuroprotectant in brain ischemia: new experimental evidences. Pharmacol Res 2008;57:266-73.
68. Liu FT. Regulatory roles of galectins in the immune response. Int Arch Allergy Immunol 2005;136:385-400.
69. Henderson NC, Sethi T. The regulation of inflammation by galectin-3. Immunol Rev 2009;230:160-71.
70. Yan YP, Lang BT, Vemuganti R, Dempsey RJ. Galectin-3 mediates post-ischemic tissue remodeling. Brain Res 2009;1288:116-24.
71. de Boer RA, Yu L, van Veldhuisen DJ. Galectin-3 in cardiac remodeling and heart failure. Curr Heart Fail Rep 2010;7:1-8.
72. Doverhag C, Hedtjärn M, Poirier F, Mallard C, Hagberg H, Karlsson A et al. Galectin-3 contributes to neonatal hypoxic-ischemic brain injury. Neurobiol Dis 2010;38:36-46.
73. Yürürer D, Teber S, Deda G, Egin Y, Akar N. The relation between cytokines, soluble endothelial protein C receptor, and factor VIII levels in Turkish pediatric stroke patients. Clin Appl Thromb Hemost 2009;15:545-51.
74. Bernard TJ, Fenton LZ, Apkon SD, Boada R, Wilkening GN, Wilkinson CC et al. Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke. J Pediatr 2010;156:651-6.
75. Karahan ZC, Deda G, Sipahi T, Elhan AH, Akar N. TNF-alpha -308G/A and IL-6 -174G/C polymorphisms in the Turkish pediatric stroke patients. Thromb Res 2005;115:393-8.
76. Shi KL, He B, Wang JJ, Zou LP. Role of TNF-alpha gene variation in idiopathic childhood ischemic stroke: a case-control study. J Child Neurol 2009;24:25-9.
77. Hoppe C, Klitz W, D'Harlingue K, Cheng S, Grow M, Steiner L et al. Confirmation of an association between the TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke 2007;38:2241-6.
78. Willmot M, Gibson C, Gray L, Murphy S, Bath P. Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radic Biol Med 2005;39:412-5.
79. Cimino M, Balduini W, Carloni S, Gelosa P, Guerrini U, Tremoli E et al. Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia. Neurotoxicology 2005;26:929-33.
80. Buller KM, Carty ML, Reinebrant HE, Wixey JA. Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate? J Neurosci Res 2009;87:599-608.
81. Peeters-Scholte C, Braun K, Koster J, Kops N, Blomgren K, Buonocore G et al. Effects of allopurinol and deferoxamine on reperfusion injury of the brain in newborn piglets after neonatal hypoxia-ischemia. Pediatr Res 2003;54:516-22.
82. Papazisis G, Pourzitaki C, Sardeli C, Lallas A, Amaniti E, Kouvelas D. Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia-ischemia. Pharmacol Res 2008;57:73-8.
83. Jatana M, Singh I, Singh AK, Jenkins D. Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res 2006;59:684-9.
84. Husson I, Mesplès B, Bac P, Vamecq J, Evrard P, Gressens P. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 2002;51:82-92.
85. Signorini C, Ciccoli L, Leoncini S, Carloni S, Perrone S, Comporti M et al. Free iron, total F-isoprostanes and total F-neuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: neuroprotective effect of melatonin. J Pineal Res 2009;46:148-54.
86. Van Bel F, Shadid M, Moison RM, Dorrepaal CA, Fontijn J, Monteiro L et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 1998;101:185-93.
87. Gunes T, Ozturk MA, Koklu E, Kose K, Gunes I. Effect of allopurinol supplementation on nitric oxide levels in asphyxiated newborns. Pediatr Neurol 2007;36:17-24.
88. Kaandorp JJ, Benders MJ, Rademaker CM, Torrance HL, Oudijk MA, de Haan TR et al. Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study. BMC Pregnancy Childbirth 2010;10:8.
89. Perrone S, Szabó M, Bellieni CV, Longini M, Bangó M, Kelen D et al. Whole body hypothermia and oxidative stress in babies with hypoxic-ischemic brain injury. Pediatr Neurol 2010;43:236-40.
90. Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M et al. Neurological outcomes at 18months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010;340:c363.
91. Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009;361:1349-58.
92. Hobbs CE, Oorschot DE. Neonatal rat hypoxia-ischemia: long-term rescue of striatal neurons and motor skills by combined antioxidant-hypothermia treatment. Brain Pathol 2008;18:443-54.
93. Cilio MR, Ferriero DM. Synergistic neuroprotective therapies with hypothermia. Semin Fetal Neonatal Med 2010;15:293-8.
94. Wainwright MS, Grundhoefer D, Sharma S, Black SM. A nitric oxide donor reduces brain injury and enhances recovery of cerebral blood flow after hypoxia-ischemia in the newborn rat. Neurosci Lett 2007;415:124-9.